Company Profile LEA Medizintechnik GmbH
|
 |
Management:
Thomas Derfuss
Address:
LEA Medizintechnik GmbH
Ludwig-Rinn-Str. 10
35452 Heuchelheim
Germany
Tel.: ++49 (0)641 32 055 064
HRB: 3504 Amtsgericht Giessen
USt.-I: DE 176 796 533
History
LEA was founded in 1995 with the objective of transferring
new optical methods for non-invasive investigation of vital parameters
from intensive clinical research into products with strong demand on the
clinical market. LEA has many years of experience in developing sensor
technology, measurement probes, flexible software solutions, ergonomic,
customer oriented user interfaces and in producing PC supported diagnostic
devices. The technical basis of the devices has been developed and verified
by an high qualified team of engineers, technicians, human biologists and
physicians in cooperation with research facilities and hospitals. Up to
now LEA and its partners have applied altogether for five patents of hardware
and measuring methods resp. acquired the rights for them (mostly worldwide).
Furthermore four brands (OptoFlow, AbTisSpec, O2C and CytoSpec) had been
registered. Essential for the competitive advantage is the know how which
is reflected by the self developed theoretical models and the interpretation
of the measured values. This knowledge is, to the bigger part, protected
knowledge of the company and generates an important basis for the current
development. New studies are permanently carried out with LEA devices.
Some are already completed and published and therewith they are showing
steadily new fields of application. The close contact to hospitals and
the permanent feedback of the users permit an optimal, application-oriented
development of our devices.
Philosophy
A basic characteristic of the organisation of LEA is
the close interlocking of the subjects of medicine, engineering, marketing
and distribution. LEA employs employees from the subjects of human biology,
medicine, electrical engineering, medical engineering, informatics and
business economics. The knowledge and qualification of each is supplemented
by the training of each in each other subject. This ensures an optimal
feedback between the employees. Thus a very close connection between development,
production and distribution is created, in order to react to a shift of
the market and to factor the customer wishes into the Development. A flat
hierarchical structure allows that the whole process flow can be seen through
by a single employee, which is an unbeatable advantage for an unbureaucratic
problem solving, to the benefit of the customer. The benefit of the customer
and a prompt and reliable solution of his problems have top priority for
LEA. For the assurance of highest demands on quality our company is accredited
according to DIN ISO 9001 and ISO 13485 and our devices are up to standard
to MPG (the german medical device act which is enforcing the medical device
directive 93/42/EEC).
Innovation / Perspectives
LEA occupies a top position by worldwide unique characteristics
of its products and proceedings, globally secured by patents. LEA devices
allow a non-invasive measurement of blood circulation, oxygen saturation
and, for the first time, the oxygen consumption in several tissue depths.
Thus it is possible to measure the tissue vitality as well as the muscle
movements in realtime without big devices. The intention of our company
is to achieve the market leadership for non-invasive optical sensors for
the measurement of oxygen supply in tissue, in Europe and the U.S. This
is provided by a permanent extension of the distribution network, both
in direct distribution and with an increasing number of highly motivated
distribution partners. A permanent extension of the fields of application
is provided by several studies in Europe and the U.S. By now there are
studies with LEA devices in many fields of application like plastic surgery,
vascular surgery, diabetes, abdominal surgery, wound healing (CVI, ulcera,
etc.), intensive care (patient monitoring), transplantation, therapy control
and cardiac surgery. LEA continues to make assiduous efforts to realize
customer loyalty by upgrading the device service and guidance and application
guidance. This is provided by a highly adaptive evaluation tool and a range
of services. In the future LEA will enter the market as a service provider
with flexible software tools. These software tools are adapted for customized
wishes and problems of data evaluation. They offer solutions for data interfaces,
signal processing, source of error analysis and the entire statistics and
archival storage. The supply of services will reach from study design and
study evaluation to the solution of data archiving.